{"id":"placebo-females","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo expectation)"}]},"_chembl":{"chemblId":"CHEMBL1251","moleculeType":"Protein","molecularWeight":"1570.35"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance or sham intervention that lacks active pharmaceutical ingredients. Its therapeutic effects, when observed, arise from psychological and neurobiological mechanisms including expectation, conditioning, and the therapeutic context rather than direct drug action. Placebo is commonly used as a control in clinical trials to establish the efficacy of active treatments.","oneSentence":"Placebo produces no pharmacological effect and works through the placebo effect, where patient expectation and clinical context influence symptom perception and outcomes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:42.103Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control arm (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT07494279","phase":"NA","title":"Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2026-03-30","conditions":"Prehypertension, Hypertension","enrollment":106},{"nctId":"NCT07420218","phase":"PHASE4","title":"Menopausal Hormones and Sympathetic Activation","status":"NOT_YET_RECRUITING","sponsor":"University of Delaware","startDate":"2026-09-01","conditions":"Perimenopausal Women","enrollment":80},{"nctId":"NCT07497113","phase":"NA","title":"The Effects of Commercially Available High Protein Drink on Amino Acid Bioavailability and Recovery From Muscle Fatiguing Exercise in 18-45-year-old Male and Female Participants.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-03-01","conditions":"Healthy Participants","enrollment":62},{"nctId":"NCT06044935","phase":"NA","title":"Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-01-08","conditions":"Overweight, Obesity","enrollment":100},{"nctId":"NCT03049462","phase":"PHASE1","title":"The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-03-13","conditions":"Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT07235917","phase":"PHASE2","title":"A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-11","conditions":"Functional Hypothalamic Amenorrhea (FHA)","enrollment":34},{"nctId":"NCT05713799","phase":"PHASE2","title":"Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Insulin Resistance, Obesity","enrollment":60},{"nctId":"NCT05840159","phase":"PHASE4","title":"A Study of Doxycycline to Treat Chlamydial Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-01-19","conditions":"Chlamydial Infection","enrollment":526},{"nctId":"NCT06533865","phase":"PHASE3","title":"Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-03-19","conditions":"FHA (Functional Hypothalamic Amenorrhea)","enrollment":114},{"nctId":"NCT00003140","phase":"PHASE3","title":"Letrozole After Tamoxifen in Treating Women With Breast Cancer","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"1998-08-24","conditions":"Breast Cancer","enrollment":5187},{"nctId":"NCT06840496","phase":"PHASE3","title":"To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome","status":"RECRUITING","sponsor":"Biomed Industries, Inc.","startDate":"2026-09-30","conditions":"Rett Syndrome","enrollment":210},{"nctId":"NCT02101775","phase":"PHASE2","title":"Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-07-21","conditions":"Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma","enrollment":124},{"nctId":"NCT03894215","phase":"PHASE2","title":"RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer","status":"TERMINATED","sponsor":"Agenus Inc.","startDate":"2019-06-01","conditions":"Cervical Cancer","enrollment":211},{"nctId":"NCT07446998","phase":"PHASE2","title":"Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss","status":"RECRUITING","sponsor":"Veru Inc.","startDate":"2026-03","conditions":"Obesity & Overweight, Mobility Disability, HOMA-IR","enrollment":200},{"nctId":"NCT06732245","phase":"PHASE2","title":"Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese","status":"NOT_YET_RECRUITING","sponsor":"Biomed Industries, Inc.","startDate":"2026-08-15","conditions":"Obesity and Overweight","enrollment":224},{"nctId":"NCT06610968","phase":"NA","title":"Acute Vitamin D Supplementation on Testosterone in Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2025-07-01","conditions":"Female Hormone Profile","enrollment":20},{"nctId":"NCT06735651","phase":"NA","title":"Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes","status":"RECRUITING","sponsor":"Georgia State University","startDate":"2024-09-20","conditions":"Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Female, Adult","enrollment":30},{"nctId":"NCT07264192","phase":"PHASE1","title":"A Study of HS-10518 in Healthy Adult Premenopausal Females in China","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2025-03-11","conditions":"Infertility, Female","enrollment":60},{"nctId":"NCT07491458","phase":"PHASE2","title":"A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Rivus Pharmaceuticals, Inc.","startDate":"2026-02-13","conditions":"MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":180},{"nctId":"NCT07448519","phase":"NA","title":"Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2023-06-13","conditions":"Obesity & Overweight, Appetite Regulation","enrollment":20},{"nctId":"NCT07218445","phase":"PHASE4","title":"The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04","conditions":"Obesity, Menopause Hot Flashes","enrollment":40},{"nctId":"NCT07484061","phase":"NA","title":"Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists","status":"RECRUITING","sponsor":"Olistic Research Labs S.L.","startDate":"2026-03-16","conditions":"Telogen Effluvium","enrollment":40},{"nctId":"NCT07255248","phase":"PHASE4","title":"Hoffa's Fat Pad Impingement (HFPI)","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-03-01","conditions":"Hoffa's Fat Pad Impingement","enrollment":62},{"nctId":"NCT04385082","phase":"PHASE1","title":"Cannabis Effects as a Function of Sex","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2021-07-08","conditions":"Pain, Abuse, Drug","enrollment":160},{"nctId":"NCT07071623","phase":"PHASE3","title":"A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-10","conditions":"Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis","enrollment":4580},{"nctId":"NCT07176780","phase":"NA","title":"Effect of Semiconductor Embedded Wearable Sleeve on Treatment of Primary Dysmenorrhea Symptoms","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-05","conditions":"Primary Dysmenorrhea, Primary Dysmenorrhea (PD), Menstrual Cramps","enrollment":100},{"nctId":"NCT07075640","phase":"PHASE1","title":"A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants","status":"RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2025-07-07","conditions":"Healthy Participants","enrollment":24},{"nctId":"NCT07202884","phase":"PHASE3","title":"A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-09-30","conditions":"Urinary Incontinence,Stress","enrollment":1000},{"nctId":"NCT04597372","phase":"PHASE2","title":"Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery","status":"RECRUITING","sponsor":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","startDate":"2021-11-03","conditions":"Urinary Retention Postoperative","enrollment":154},{"nctId":"NCT05037487","phase":"PHASE1","title":"Evaluation of Smoked THC and CBD in Men and Women","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-09-01","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":19},{"nctId":"NCT06641466","phase":"PHASE3","title":"A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-03-11","conditions":"Menstrual Migraine","enrollment":723},{"nctId":"NCT07486115","phase":"PHASE1","title":"A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-04-07","conditions":"Healthy","enrollment":136},{"nctId":"NCT07485231","phase":"NA","title":"Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-04-01","conditions":"Post Traumatic Stress Disorder, Trauma","enrollment":30},{"nctId":"NCT06984926","phase":"PHASE1","title":"A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-06-06","conditions":"Healthy","enrollment":47},{"nctId":"NCT06812754","phase":"PHASE2","title":"A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2025-03-10","conditions":"Hot Flashes","enrollment":150},{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT02720094","phase":"PHASE2, PHASE3","title":"Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-19","conditions":"HIV Infections","enrollment":4570},{"nctId":"NCT07257029","phase":"PHASE2","title":"Topical Ketotifen 0.25% for Secondary Vestibulodynia","status":"RECRUITING","sponsor":"Center for Vulvovaginal Disorders","startDate":"2026-01-02","conditions":"Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, Vulvodynia","enrollment":54},{"nctId":"NCT07480668","phase":"NA","title":"Aromatherapy for Mental Health Promotion in IVF Patients","status":"RECRUITING","sponsor":"Federal University of Minas Gerais","startDate":"2026-03","conditions":"Anxiety, Stress, Depression Disorder","enrollment":120},{"nctId":"NCT06991257","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-06-19","conditions":"Heart Failure","enrollment":620},{"nctId":"NCT07475208","phase":"NA","title":"NR and Exercise for Blood Pressure","status":"NOT_YET_RECRUITING","sponsor":"ZHANG Jiaqi","startDate":"2026-04","conditions":"Hypertension (HTN)","enrollment":112},{"nctId":"NCT07480083","phase":"NA","title":"Low-level Laser Therapy in Pain and Perineal Healing in the Immediate Postpartum Period: a Randomized Clinical Trial.","status":"NOT_YET_RECRUITING","sponsor":"Instituto Materno Infantil Prof. Fernando Figueira","startDate":"2026-04-01","conditions":"Pain, Perineal Healing","enrollment":206},{"nctId":"NCT06389539","phase":"NA","title":"Synbiotic to Attenuate Resorption of the Skeleton","status":"RECRUITING","sponsor":"Hebrew SeniorLife","startDate":"2024-08-12","conditions":"Osteoporosis, Inflammation, Aging","enrollment":220},{"nctId":"NCT06728761","phase":"NA","title":"Gastric Emptying With Trou Normand","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2025-12-19","conditions":"Healthy Volunteer","enrollment":8},{"nctId":"NCT07229976","phase":"NA","title":"Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2026-03-20","conditions":"Chronic Insomnia During Perimenopause and Menopause","enrollment":198},{"nctId":"NCT07474753","phase":"NA","title":"Coffee Increases Physical and Cognitive Performance Both in Men and Women","status":"COMPLETED","sponsor":"Northumbria University","startDate":"2020-12-04","conditions":"Dietary Supplement, Exercise","enrollment":69},{"nctId":"NCT07474077","phase":"PHASE3","title":"Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-05-01","conditions":"Post Partum Haemorrhage","enrollment":88},{"nctId":"NCT06200467","phase":"PHASE1","title":"A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-13","conditions":"Overweight, Obesity","enrollment":110},{"nctId":"NCT05925803","phase":"PHASE3","title":"Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-11-08","conditions":"Systemic Sclerosis, Scleroderma","enrollment":314},{"nctId":"NCT06645847","phase":"NA","title":"Targeting Aging With a Ketone Ester for Function in Frailty","status":"RECRUITING","sponsor":"Buck Institute for Research on Aging","startDate":"2025-02-05","conditions":"Frail Elderly, Aging, Immune Function","enrollment":180},{"nctId":"NCT06579690","phase":"PHASE3","title":"Use of Preoperative Sodium Bicarbonate Among Women With Obstructed Labor","status":"RECRUITING","sponsor":"Busitema University","startDate":"2025-05-06","conditions":"Obstructed Labor","enrollment":472},{"nctId":"NCT05138822","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-05-18","conditions":"Uncomplicated Urinary Tract Infections, Urinary Tract Infections","enrollment":140},{"nctId":"NCT06206421","phase":"PHASE3","title":"A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause","status":"ACTIVE_NOT_RECRUITING","sponsor":"Astellas Pharma Inc","startDate":"2024-02-22","conditions":"Hot Flashes","enrollment":277},{"nctId":"NCT03104517","phase":"PHASE3","title":"Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cook MyoSite","startDate":"2019-04-23","conditions":"Stress Urinary Incontinence","enrollment":96},{"nctId":"NCT05776277","phase":"PHASE3","title":"Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cook MyoSite","startDate":"2024-03-21","conditions":"Fecal Incontinence","enrollment":200},{"nctId":"NCT06579209","phase":"NA","title":"NAD+ Oral Supplement Pilot Intervention in Adult Females","status":"COMPLETED","sponsor":"University of Rhode Island","startDate":"2024-12-01","conditions":"Cognitive Change, Inflammation, Neurodegenerative Diseases","enrollment":53},{"nctId":"NCT06375668","phase":"NA","title":"The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women","status":"COMPLETED","sponsor":"Nordic Biotic Sp. z o.o.","startDate":"2022-03-15","conditions":"Osteoporosis, Postmenopausal, Bone Density, Low","enrollment":170},{"nctId":"NCT07260669","phase":"PHASE2","title":"A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis","status":"RECRUITING","sponsor":"Gesynta Pharma AB","startDate":"2025-10-15","conditions":"Endometriosis","enrollment":190},{"nctId":"NCT06982313","phase":"","title":"Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms","status":"COMPLETED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"1996-07-01","conditions":"Breast Cancer Invasive","enrollment":1545},{"nctId":"NCT07027800","phase":"NA","title":"High Intensity Resistance Training + Creatine in Perimenopause","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-06-02","conditions":"Perimenopause","enrollment":55},{"nctId":"NCT06641089","phase":"PHASE3","title":"Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response","status":"RECRUITING","sponsor":"MoonLake Immunotherapeutics AG","startDate":"2024-10-15","conditions":"Arthritis, Psoriatic","enrollment":600},{"nctId":"NCT02712723","phase":"PHASE2","title":"Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qamar Khan","startDate":"2016-02","conditions":"Breast Cancer","enrollment":121},{"nctId":"NCT06250283","phase":"NA","title":"Resveratrol for the Prevention of Bone Loss in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Delaware","startDate":"2024-02-02","conditions":"Low Bone Mass","enrollment":52},{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT07404449","phase":"PHASE1","title":"Sex-Speciffic Longevity Food Supplements","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Primorska","startDate":"2026-03-07","conditions":"Aging","enrollment":60},{"nctId":"NCT04872660","phase":"PHASE4","title":"Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET","status":"RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":800},{"nctId":"NCT06598488","phase":"NA","title":"Beetroot Juice: A Natural Boost for Cardiovascular Health in Postmenopausal Women?","status":"COMPLETED","sponsor":"Western Norway University of Applied Sciences","startDate":"2025-09-09","conditions":"Post-menopause","enrollment":14},{"nctId":"NCT06973109","phase":"PHASE2","title":"Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nitin Agarwal","startDate":"2026-03-20","conditions":"Osteoporosis, Post-menopausal","enrollment":36},{"nctId":"NCT06285214","phase":"PHASE1","title":"Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome","status":"COMPLETED","sponsor":"Imbrium Therapeutics","startDate":"2022-05-26","conditions":"Interstitial Cystitis/Bladder Pain Syndrome","enrollment":47},{"nctId":"NCT07118891","phase":"PHASE1, PHASE2","title":"Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause","status":"RECRUITING","sponsor":"AbCellera Biologics Inc.","startDate":"2025-06-23","conditions":"Vasomotor Symptoms Associated With Menopause, Healthy Volunteers","enrollment":136},{"nctId":"NCT07455669","phase":"NA","title":"Effects of Microgalvanic Current on Body Satisfaction and Quality of Life in Women With Striae Alba","status":"COMPLETED","sponsor":"Federal University of the Valleys of Jequitinhonha and Mucuri","startDate":"2024-04-08","conditions":"White Stretch Marks (Striae Albae)","enrollment":61},{"nctId":"NCT06878001","phase":"PHASE4","title":"CaroRite™ for Skin Health and Signs of Ageing","status":"COMPLETED","sponsor":"RDC Clinical Pty Ltd","startDate":"2025-07-07","conditions":"Healthy Volunteer, Skin Condition, Ageing Signs","enrollment":80},{"nctId":"NCT05318534","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease","status":"RECRUITING","sponsor":"Gliknik Inc.","startDate":"2022-04-08","conditions":"First in Man Study to Evaluate Initial Safety","enrollment":70},{"nctId":"NCT05362292","phase":"PHASE4","title":"TReating Incontinence for Underlying Mental and Physical Health","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-10-04","conditions":"Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder","enrollment":270},{"nctId":"NCT07452978","phase":"PHASE2","title":"Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2026-09-01","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":34},{"nctId":"NCT07453069","phase":"PHASE2","title":"Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle","status":"NOT_YET_RECRUITING","sponsor":"Freya Biosciences ApS","startDate":"2026-04-15","conditions":"Vaginal Dysbiosis","enrollment":30},{"nctId":"NCT07080931","phase":"PHASE3","title":"Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia","status":"RECRUITING","sponsor":"Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.","startDate":"2025-02-24","conditions":"Androgenetic Alopecia","enrollment":294},{"nctId":"NCT00616967","phase":"PHASE2","title":"Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2008-05","conditions":"Breast Cancer","enrollment":68},{"nctId":"NCT03319498","phase":"NA","title":"Postpartum Urinary Retention With Essential Oils (PURE)","status":"TERMINATED","sponsor":"Mount Carmel Health System","startDate":"2018-01-01","conditions":"Urinary Retention","enrollment":77},{"nctId":"NCT06524895","phase":"NA","title":"Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2022-11-09","conditions":"Breast Cancer","enrollment":32},{"nctId":"NCT06190509","phase":"PHASE1, PHASE2","title":"Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"LimmaTech Biologics AG","startDate":"2023-12-06","conditions":"Recurrent Vulvovaginal Candidiasis","enrollment":251},{"nctId":"NCT05681299","phase":"PHASE4","title":"Effects of GH and Lirglutide on AgRP","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-05-01","conditions":"Healthy, Growth Hormone Deficiency","enrollment":40},{"nctId":"NCT07446361","phase":"NA","title":"A Study to Evaluate the Efficacy of Collagen 16 Serum Alone, Against and as an Adjunct to Radiesse® Biostimulation Procedure in Female Trial Participants With Aged Skin","status":"NOT_YET_RECRUITING","sponsor":"Vichy Laboratoires","startDate":"2026-03-01","conditions":"Wrinkle Appearance, Skin Quality","enrollment":180},{"nctId":"NCT07441109","phase":"NA","title":"Shatavari Root Extract for Perimenopausal Symptoms","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-11","conditions":"Perimenopause, Women Health","enrollment":60},{"nctId":"NCT07441096","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-20","conditions":"Premenstrual Syndrome, Women Health","enrollment":60},{"nctId":"NCT06379074","phase":"NA","title":"Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health","status":"RECRUITING","sponsor":"University of Rome G. Marconi","startDate":"2024-05-06","conditions":"Postpartum Depression, Insomnia, Stress","enrollment":114},{"nctId":"NCT05003648","phase":"PHASE4","title":"Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-04-01","conditions":"Adrenoleukodystrophy, Restless Legs Syndrome","enrollment":24},{"nctId":"NCT05869812","phase":"PHASE2","title":"Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-05-29","conditions":"Atrophy","enrollment":30},{"nctId":"NCT07444138","phase":"NA","title":"Effects of Beetroot Extract on Blood Pressure and Exercise in Hypertensive Older Women","status":"RECRUITING","sponsor":"São Paulo State University","startDate":"2025-10-08","conditions":"Hypertension, Hypertension (HTN)","enrollment":20},{"nctId":"NCT05039515","phase":"PHASE2","title":"A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Clementia Pharmaceuticals Inc.","startDate":"2021-12-01","conditions":"Fibrodysplasia Ossificans Progressiva","enrollment":113},{"nctId":"NCT06079671","phase":"PHASE3","title":"Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2023-09-22","conditions":"Locally Advanced Cervical Cancer","enrollment":800},{"nctId":"NCT03764098","phase":"PHASE2","title":"Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders","status":"RECRUITING","sponsor":"Yale University","startDate":"2020-08-10","conditions":"Alcohol Use","enrollment":160},{"nctId":"NCT06122207","phase":"NA","title":"Effect of a Probiotic on the Female Genital Tract Microbiota of Participants With Fertility Disorders.","status":"RECRUITING","sponsor":"ProbiSearch SL","startDate":"2024-02-14","conditions":"Fertility Disorders","enrollment":120},{"nctId":"NCT01602380","phase":"PHASE3","title":"A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-10-17","conditions":"Hormone Receptor Positive Breast Cancer","enrollment":462},{"nctId":"NCT06173661","phase":"PHASE4","title":"Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-03-01","conditions":"Migraine, Menstrual Migraine, Menstrually Related Migraine","enrollment":72},{"nctId":"NCT05895578","phase":"NA","title":"Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection.","status":"RECRUITING","sponsor":"ProbiSearch SL","startDate":"2023-06-21","conditions":"Recurrent Urinary Tract Infection","enrollment":90},{"nctId":"NCT05067387","phase":"PHASE1","title":"Evaluation of Oral THC and CBD in Men and Women","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-04-15","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":22},{"nctId":"NCT07431775","phase":"","title":"Saphnelo Use in Females of Child-bearing Potential","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-10-01","conditions":"Systemic Lupus Erythematosus","enrollment":26000000},{"nctId":"NCT07433049","phase":"NA","title":"Impact of Supplementation in Improving Metabolic Health Outcomes (ISMOS) Study","status":"RECRUITING","sponsor":"Institute for Human Development and Potential (IHDP), Singapore","startDate":"2026-01-20","conditions":"Glucose Control, Mental Health, Musculoskeletal Health","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Saline physiological 5 ml"],"phase":"marketed","status":"active","brandName":"Placebo females","genericName":"Placebo females","companyName":"Ullevaal University Hospital","companyId":"ullevaal-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces no pharmacological effect and works through the placebo effect, where patient expectation and clinical context influence symptom perception and outcomes. Used for Clinical trial control arm (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}